CTOs on the Move

Munson Healthcare

www.munsonhealthcare.org

 
Munson Healthcare is northern Michigan`s largest and leading health care system. Based in Traverse City, Mich., our team of medical experts, nine award-winning community hospitals, and related organizations serve people in 30 counties. Most of the region`s 540,000 residents can receive comprehensive quality care in or near their local community with access to sophisticated diagnostic technology such as 3D tomography, advanced cancer and heart treatments, and the latest robotic technology, stereotactic radiosurgery, and non-invasive surgical procedures. Patients in northern Michigan also benefit from Munson Healthcare`s collaborative partnerships with major health care systems, including Mayo Clinic, Michigan Medicine, Spectrum Health, and ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Michael Saad
Chief Information Officer Profile

Similar Companies

Asterand, plc

Asterand, plc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Asterand, plc is based in Detroit, MI. You can find more information on Asterand, plc at www.asterand.com

LMA North America

LMA North America is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Home Network

Medical Home Network (MHN) is a formal provider collaborative working to improve the health of Medicaid recipients in Chicago by enhancing care coordination and quality, improving access and reducing fragmentation and cost, all while reinforcing the me...

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.

FSGC Topeka

Watching your child struggle is hard. FSGC offers professional child counseling in Topeka to help them overcome their unique struggles.